MyDx Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 7
Employees
  • Stock Symbol
  • MYDX
Stock Symbol
  • Investments
  • 1

MyDx General Information

Description

MyDx Inc is a science and technology company and creator of MyDx (My Diagnostic). It is the first multi-use handheld chemical analyzer that will test for pesticides in the food, chemicals, and toxins in the air and the safety and potency of the cannabis samples. The business activities of the group are functioned through Consumer Products, Data Analytics, Biopharmaceutical, and Software as a Service segment. The company distributes its products through various channels, including e-commerce through the company's Website, direct to retail, amazon.com, and sales through affiliate partners. Geographically, the business activities are carried out through the region of United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Stock Exchange
PINX
Primary Office
  • 4225 Executive Square
  • Suite 600
  • La Jolla, CA
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MyDx Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$590K 108M

MyDx Financials Summary

In Thousands,
USD
TTM 30-Sep-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016
EV 4,898 13,722 13,331 1,203
Revenue 258 269 421 808
EBITDA (2,108) (8,126) (4,820) (13,697)
Net Income (2,954) (8,332) (5,234) (16,502)
Total Assets 352 436 400 490
Total Debt 699 439 299 557
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MyDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MyDx‘s full profile, request access.

Request a free trial

MyDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore MyDx‘s full profile, request access.

Request a free trial

MyDx Executive Team (9)

Name Title Board Seat Contact Info
Daniel Yazbeck Chief Executive Officer & Chief Financial Officer, Finance
Robert Lewis Chief Marketing Officer
Nicholas Hadler Co-Founder & Vice President of Operations
Jessica Peatross Chief Medical Officer
You’re viewing 4 of 9 executive team members. Get the full list »

MyDx Board Members (3)

Name Representing Role Since
Thomas Gruber MyDx Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

MyDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MyDx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MyDx‘s full profile, request access.

Request a free trial

MyDx Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 (00000000) 30-Apr-2015 000000000000000000 Diagnostic Equipment
To view MyDx’s complete acquisitions history, request access »